Search Within

Ghassan Abou-Alfa

Formats
  1. Meeting Abstract (262)
  2. Journal Article (246)
  3. Review (27)
  4. Book Section (16)
  5. Editorial (8)
  6. Book Whole (4)
  7. Correspondence (4)
  8. Guidelines (4)
  9. Miscellaneous (3)
  10. Research Letter (1)
Groups
  1. Department of Medicine (575)
  2. Gastrointestinal Oncology Service (575)
  3. Solid Tumor Oncology Division (575)
  4. Center for Pancreatic Cancer Research (215)
  5. Epidemiology and Biostatistics (122)
  6. Surgery (103)

More Groups

People
  1. Eileen O'Reilly (156)
  2. James Harding (130)
  3. William Jarnagin (66)
  4. Marinela Capanu (65)
  5. Leonard Saltz (55)
  6. Imane El Dika (54)

More People

Years
  1. 2025 (20)
  2. 2024 (52)
  3. 2023 (48)
  4. 2022 (53)
  5. 2021 (46)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Annals of Oncology (53)
  3. Gastrointestinal Cancer Research (21)
  4. Oncology Research and Treatment (18)
  5. Annals of Surgical Oncology (15)
  6. Cancer (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (182)
  2. Oxford University Press (65)
  3. Springer (36)
  4. Wiley Blackwell (30)
  5. Elsevier Inc. (25)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (575)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical activity of cabozantinib in patients with advanced hepatocellular carcinoma previously treated with anti-VEGF and immuno-oncology therapy: Subgroup analysis from the phase 3 CELESTIAL trial
    Meeting Abstract

    Trojan, J.; Abou-Alfa, G. K.; Cheng, A. L.; Saletan, S.; Kelley, R. K.; El-Khoueiry, A. B.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Clinical value of atezolizumab plus bevacizumab for first-line unresectable hepatocellular carcinoma (HCC): A network meta-analysis
    Meeting Abstract

    Vogel, A.; Rimassa, L.; Sun, H. C.; Abou-Alfa, G. K.; El-Khoueiry, A. B.; Pinato, D. J.; Daigl, M.; Alvarez, J. S.; Orfanos, P.; Leibfried, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in hepatopancreaticobiliary (HPB) cancers
    Meeting Abstract

    Park, W.; Sokol, E.; Chen, J.; Yu, K. H.; Khalil, D.; Harding, J. J.; El Dika, I. H.; Riaz, N.; Abou-Alfa, G. K.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC)
    Meeting Abstract

    Kelley, R. K.; Sangro, B.; Harris, W. P.; Ikeda, M.; Okusaka, T.; Kang, Y. K.; Qin, S.; Tai, W. M. D.; Lim, H. Y.; Yau, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of post second-line chemotherapy treatment outcomes for patients with advanced or metastatic cholangiocarcinoma and FGFR2 fusions
    Meeting Abstract

    Javle, M. M.; Sadeghi, S.; El-Khoueiry, A. B.; Goyal, L.; Philip, P. A.; Kelley, R. K.; Borbath, I.; Macarulla, T.; Yong, W. P.; Tanasanvimon, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • IDH1 mutation detection in plasma circulating tumor DNA (ctDNA) and association with clinical response in patients with advanced intrahepatic cholangiocarcinoma (IHC) from the phase III ClarIDHy study
    Meeting Abstract

    Aguado, E.; Abou-Alfa, G. K.; Zhu, A. X.; Macarulla, T.; Fan, B.; Nejad, P.; Choe, S.; Jiang, L. W.; Gliser, C.; Pandya, S. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PROOF: A multicenter, open-label, randomized, phase III trial of infigratinib vs gemcitabine + cisplatin in patients with advanced cholangiocarcinoma with FGFR2 gene rearrangements
    Meeting Abstract

    Abou-Alfa, G. K.; Borbath, I.; Cohn, A. L.; Goyal, L.; Lamarca, A.; Macarulla, T.; Oh, D. Y.; Roychowdhury, S.; Sadeghi, S.; Shroff, R. T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
    Journal Article

    El Dika, I.; Capanu, M.; Chou, J. F.; Harding, J. J.; Ly, M.; Hrabovsky, A. D.; Do, R. K. G.; Shia, J.; Millang, B.; Ma, J.; more...
    Cancer Medicine (2020)

    Fulltext@MSK | Save
  • ESMO presidential symposium wrap up: The ClarIDHy trial
    Miscellaneous

    Abou-Alfa, G. K.
    ESMO Open (2020)

    Fulltext@MSK | Save
  • NRF2 dysregulation in hepatocellular carcinoma and ischemia: A cohort study and laboratory investigation
    Journal Article

    Ziv, E.; Zhang, Y.; Kelly, L.; Nikolovski, I.; Boas, F. E.; Erinjeri, J. P.; Cai, L.; Petre, E. N.; Brody, L. A.; Covey, A. M.; more...
    Radiology (2020)

    Fulltext@MSK | Save